Newsletter Subscription


Friday, Jan 20, 2017


Another Major European Airport Selects Implant Sciences' QS-B220 Explosives and Drugs Trace Detector for Aviation Security

Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold and shipped its Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detector to a major European airport. This marks the third major European airport to select the QS-B220 for aviation security within the last four months.

"We are pleased to have won this contract in a competitive bidding situation. Our QS-B220 was selected over competing systems by yet another well-known international European airport," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "The customer conducted an extensive trial of the system, during which they we able to evaluate first hand our QS-B220's consistent and positive identification of a broad range of explosives and drugs, as well as the excellent level of local training and support provided by our distributor."


Related Research on ASDReports.com:
C4ISR Market - Forecast to 2021

Source : Implant Sciences Corp.

Published on ASDNews: Dec 12, 2012

 

Defence Satellites 2017 Conference

May 23 - 25, 2017 - Rome, Italy

Register More info


Aircraft Asset Management Seminar 2017

Feb 13 - 14, 2017 - Hong Kong, Hong Kong

Register More info


Air Mission Planning and Support 2017 Conference

Apr 5 - 6, 2017 - London, United Kingdom

Register More info


© 2004-2017 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk